Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Basic Res Cardiol. 2011 Feb 2;106(3):473–483. doi: 10.1007/s00395-011-0155-2

Table 1.

Echocardiographic measurements (n = 14)

HF + NBI-27914 HF + vehicle SHAM + NBI-27914 SHAM + vehicle
Measurements at baseline
 LVEDV (ml) 0.72 ± 0.08* 0.71 ± 0.07* 0.36 ± 0.05 0.39 ± 0.05
 LVEDV/Mass 1.05 ± 0.08* 1.08 ± 0.09* 0.54 ± 0.05 0.59 ± 0.06
 LVEF 0.35 ± 0.04* 0.37 ± 0.05* 0.82 ± 0.05 0.84 ± 0.07
 IZ (%) 48 ± 4 46 ± 4
Measurements at 4 weeks
 LVEDV (ml) 1.35 ± 0.07*, 1.40 ± 0.08*, 0.32 ± 0.03 0.35 ± 0.04
 LVEDV/Mass 1.61 ± 0.12*, 1.70 ± 0.15*, 0.56 ± 0.05 0.61 ± 0.06
 LVEF 0.34 ± 0.03*, 0.24 ± 0.03*, 0.83 ± 0.07 0.80 ± 0.06
 IZ (%) 46 ± 4 50 ± 5

Values are mean ± SEM

SHAM sham-operated control, HF heart failure, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, IZ% percent ischemic zone

*

P < 0.05 versus SHAM + NBI-27914 or SHAM + vehicle;

P < 0.05 HF + NBI-27914 versus HF + vehicle;

P < 0.05, 4 weeks versus 24 h value